BG105361A - Genes of the 1-desoxy-d-xylulose biosynthetic pathway - Google Patents

Genes of the 1-desoxy-d-xylulose biosynthetic pathway

Info

Publication number
BG105361A
BG105361A BG105361A BG10536101A BG105361A BG 105361 A BG105361 A BG 105361A BG 105361 A BG105361 A BG 105361A BG 10536101 A BG10536101 A BG 10536101A BG 105361 A BG105361 A BG 105361A
Authority
BG
Bulgaria
Prior art keywords
xylulose
desoxy
biosynthetic pathway
genes
gene
Prior art date
Application number
BG105361A
Other languages
Bulgarian (bg)
Inventor
Hassan Jomaa
Original Assignee
Jomaa Pharmaka Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19923567A external-priority patent/DE19923567A1/en
Application filed by Jomaa Pharmaka Gmbh filed Critical Jomaa Pharmaka Gmbh
Publication of BG105361A publication Critical patent/BG105361A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/711—Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0006—Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0093—Oxidoreductases (1.) acting on CH or CH2 groups (1.17)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1022—Transferases (2.) transferring aldehyde or ketonic groups (2.2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y101/00—Oxidoreductases acting on the CH-OH group of donors (1.1)
    • C12Y101/01—Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
    • C12Y101/01267—1-Deoxy-D-xylulose-5-phosphate reductoisomerase (1.1.1.267)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y117/00—Oxidoreductases acting on CH or CH2 groups (1.17)
    • C12Y117/07—Oxidoreductases acting on CH or CH2 groups (1.17) with an iron-sulfur protein as acceptor (1.17.7)
    • C12Y117/07001—(E)-4-Hydroxy-3-methylbut-2-enyl-diphosphate synthase (1.17.7.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y202/00—Transferases transferring aldehyde or ketonic groups (2.2)
    • C12Y202/01—Transketolases and transaldolases (2.2.1)
    • C12Y202/01007—1-Deoxy-D-xylulose-5-phosphate synthase (2.2.1.7)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Analytical Chemistry (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The invention relates to the 1-desoxy-D-xylulose-5-phosphate reductoisomerase gene, the 1-desoxy-D-xylulose-5-phosphate-synthase gene and the gcpE gene of the 1-deoxy-D-xylulose biosynthetic pathway and to their use for the transforming vectors, host organisms and plants and for determining substances that inhibit this biosynthetic pathway. 18 claims
BG105361A 1998-09-22 2001-03-19 Genes of the 1-desoxy-d-xylulose biosynthetic pathway BG105361A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19843279 1998-09-22
DE19923567A DE19923567A1 (en) 1998-09-22 1999-05-21 Genes of the 1-deoxy-D-xylulose biosynthetic pathway
PCT/EP1999/007055 WO2000017233A2 (en) 1998-09-22 1999-09-22 Genes of the 1-desoxy-d-xylulose biosynthetic pathway

Publications (1)

Publication Number Publication Date
BG105361A true BG105361A (en) 2001-10-31

Family

ID=26048996

Family Applications (1)

Application Number Title Priority Date Filing Date
BG105361A BG105361A (en) 1998-09-22 2001-03-19 Genes of the 1-desoxy-d-xylulose biosynthetic pathway

Country Status (23)

Country Link
EP (1) EP1115849B1 (en)
JP (1) JP2002526061A (en)
CN (1) CN1319134A (en)
AP (1) AP2001002104A0 (en)
AT (1) ATE317007T1 (en)
AU (1) AU767213B2 (en)
BG (1) BG105361A (en)
BR (1) BR9914028A (en)
CA (1) CA2343919A1 (en)
CZ (1) CZ2001990A3 (en)
DE (1) DE59913101D1 (en)
EE (1) EE200100174A (en)
HR (1) HRP20010215A2 (en)
HU (1) HUP0203649A2 (en)
ID (1) ID29772A (en)
IL (1) IL141888A0 (en)
IS (1) IS5872A (en)
NO (1) NO20011459L (en)
OA (1) OA11656A (en)
PL (1) PL348428A1 (en)
SK (1) SK3922001A3 (en)
TR (1) TR200100836T2 (en)
WO (1) WO2000017233A2 (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2736981A1 (en) 1998-04-14 1999-10-21 Kyowa Hakko Bio Co., Ltd. Process for producing isoprenoid compounds by microorganisms
ATE316578T1 (en) 1999-04-15 2006-02-15 Calgene Llc NUCLEIC ACID SEQUENCES FOR PROTEINS INVOLVED IN TOCOPHEROL BIOSYNTHESIS
DE19918949A1 (en) * 1999-04-27 2000-11-23 Basf Ag Overexpression of a DNA sequence coding for a 1-deoxy-D-xylulose-5-phosphate reductoisomerase in plants
EP1179187A1 (en) * 1999-05-21 2002-02-13 Jomaa Pharmaka GmbH Use of genes of the deoxy-d-xylulose phosphate biosynthetic pathway for altering the concentration of isoprenoid
WO2001011055A1 (en) 1999-08-04 2001-02-15 Adelbert Bacher Isoprenoid biosynthesis
US6872815B1 (en) 2000-10-14 2005-03-29 Calgene Llc Nucleic acid sequences to proteins involved in tocopherol synthesis
DE10021688A1 (en) * 2000-05-05 2001-11-15 Hassan Jomaa New DNA sequences involved in isoprenoid biosynthesis, useful in screening for compounds with e.g. antimicrobial and herbicidal activity
DE10027821A1 (en) 2000-06-05 2001-12-06 Adelbert Bacher New intermediate in isoprenoid biosynthesis, useful in screening for potential herbicides, comprises mutant encoding-enzymes sequences for imparting herbicide resistance
CA2418436C (en) 2000-08-07 2017-07-11 Monsanto Technology, Llc Methyl-d-erythritol phosphate pathway genes
DE10201458A1 (en) 2001-04-11 2002-10-17 Adelbert Bacher New proteins involved in isoprenoid biosynthesis, useful in screening for inhibitors, also new intermediates, potential therapeutic agents, nucleic acids and antibodies
US7161061B2 (en) 2001-05-09 2007-01-09 Monsanto Technology Llc Metabolite transporters
EP1392106B1 (en) 2001-05-09 2008-12-31 Monsanto Technology LLC Tyra genes and uses thereof
EP1408984B1 (en) * 2001-07-20 2008-10-22 BioAgency AG Organo-phosphorous compounds for activating gamma/delta t cells
US7244877B2 (en) 2001-08-17 2007-07-17 Monsanto Technology Llc Methyltransferase from cotton and uses thereof
AU2002342114B2 (en) 2001-10-25 2008-07-31 Monsanto Technology Llc Aromatic methyltransferases and uses thereof
BR0308740A (en) 2002-03-19 2007-01-09 Monsanto Technology Llc homogenous prenyl transferase ("hpt") nucleic acids and polypeptides, and their use
BR0313270A (en) 2002-08-05 2005-08-02 Monsanto Technology Llc Genes related to tocopherol biosynthesis and uses
CN106978425B (en) * 2017-02-17 2019-10-18 华中农业大学 The albumen of Babesia orientalis 1-deoxy-D-xylulose -5- phosphoric acid reduction isomerase gene and its coding
EP3720944A1 (en) 2017-12-07 2020-10-14 Zymergen Inc. Engineered biosynthetic pathways for production of (6e)-8-hydroxygeraniol by fermentation
CN111868047A (en) 2017-12-21 2020-10-30 齐默尔根公司 Nepetalactol oxidoreductase, nepetalactol synthase and microorganism capable of producing nepetalactone
CN109342634A (en) * 2018-12-07 2019-02-15 西北大学 A kind of method of column front derivation-HPLC measurement DXS enzymatic activity

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19752700A1 (en) * 1997-11-28 1999-06-02 Hoechst Schering Agrevo Gmbh 1-Deoxy-D-xylulose-5-phosphate synthase protein and modulators
TR200002972T2 (en) * 1998-04-14 2001-01-22 Jomaa Hassan Process for determination of active substances and chemical active substances for inhibition of the 1-deoxy-D-xylulose-5-phosphate biosynthesis pathway

Also Published As

Publication number Publication date
CN1319134A (en) 2001-10-24
BR9914028A (en) 2001-07-03
AU6194799A (en) 2000-04-10
TR200100836T2 (en) 2001-10-22
OA11656A (en) 2004-12-08
SK3922001A3 (en) 2001-09-11
EE200100174A (en) 2002-08-15
IS5872A (en) 2001-02-28
AU767213B2 (en) 2003-11-06
HUP0203649A2 (en) 2003-02-28
CZ2001990A3 (en) 2002-01-16
AP2001002104A0 (en) 2001-03-31
WO2000017233A3 (en) 2000-05-25
NO20011459D0 (en) 2001-03-22
JP2002526061A (en) 2002-08-20
DE59913101D1 (en) 2006-04-13
ATE317007T1 (en) 2006-02-15
HRP20010215A2 (en) 2002-06-30
NO20011459L (en) 2001-05-22
EP1115849B1 (en) 2006-02-01
CA2343919A1 (en) 2000-03-30
IL141888A0 (en) 2002-03-10
ID29772A (en) 2001-10-11
EP1115849A2 (en) 2001-07-18
WO2000017233A2 (en) 2000-03-30
PL348428A1 (en) 2002-05-20

Similar Documents

Publication Publication Date Title
BG105361A (en) Genes of the 1-desoxy-d-xylulose biosynthetic pathway
EP1340765A3 (en) Inverted chimeric and hybrid oligonucleotides
BG104780A (en) Inhibitors of phospholipase enzymes
MX206851B (en) Substituted aryl or heteroarylamides having retinoid-like biological activity.
DE59611481D1 (en) Chromatin-regulatorgene
WO2001085664A3 (en) Compounds and methods for regulating bacterial growth and pathogenesis
MX9706109A (en) Dna molecules, preparation thereof and use thereof in gene therapy.
MXPA04000179A (en) Synthetic double stranded oligonucleotides for targeted inhibition of gene expression.
YU53899A (en) Use of cyclooxygenase-2 inhibitors or derivatives thereof in preventing cardiovascular disorders
ES2180622T3 (en) OLIGONUCLEOTIDOS ANTISENTIDO WITH INHIBITING ACTIVITY OF TUMORIGENICITY.
AU6147096A (en) Use of nucleic acid ligands in flow cytometry
NO972911L (en) Stabilized ribozyme analogues
EP0840608A4 (en) Treatment and prevention of neoplasms with salts of aminoimidazole carboxamide and 5-amino or substituted amino 1,2,3-triazoles
BG101966A (en) Application of 1l-agonist for the treatment of lack of urine retention
EP0881914A4 (en)
DE69824433D1 (en) Proteintyrosinphosphatase inhibitoren
ATE275956T1 (en) ALTERATION OF DNA METHYLTRANSFERASE THROUGH COMBINATION THERAPY
GR3034534T3 (en) Novel polymer supports for nucleic acid synthesis
ATE478686T1 (en) MEDICATIONS FOR MASSIVE TUMORS CONTAINING INHIBITORS OF WILMS' TUMOR EXPRESSION
FR2744455B1 (en) NOVEL NUCLEIC ACID SEQUENCES OF THE FAMILY OF TUMOR SUPPRESSOR FACTORS, CORRESPONDING EXPRESSION PRODUCTS AND THEIR APPLICATIONS
AU7296696A (en) Deodorising formulations containing cationic biopolymers, aluminium chlorhydrate and esterase inhibitors
NO960826L (en) Use of enzymes from krill in substances
ZA981659B (en) Acarbose ACB cluster isolation of further acarbose biosynthesis and acarbose metabolism genes from actinoplanes SP.SE50/110 and their use
MXPA04000178A (en) Novel oligoribonucleotide derivatives for the targeted inhibition of gene expression.
AU5069400A (en) Use of genes of the deoxy-d-xylulose phosphate biosynthetic pathway for altering the concentration of isoprenoid